We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > OPDP

News List

Pharma ad police issues 2019's first warning over promotion of unapproved imaging drug fiercepharma
March 19, 2019
And the first FDA drug marketing warning letter of the year goes to ... a drug that’s not yet approved. The agency's Office of Prescription Drug Promotion (OPDP) issued an untitled letter (PDF) to Phoenix Molecular Imaging Center for its investigational S
With only 2 warnings in 2017, pharma's ad police hits historic low fiercepharma
November 15, 2017
As the end of the year nears, the pharma industry can usually look back at FDA enforcement letters for insight into the agency's thinking and guidance on marketing communications. But this year, there’s not much to review.